As part of expenditure optimization, the Ministry of Finance has reduced the volume of subsidies for preferential lending to domestic manufacturers of medicines and medical devices by 100 million som. The department announced this in an explanatory note to the draft adjusted republican budget in late October.

Allocated Funds Volume

Initially, significantly more funds were planned to support the pharmaceutical industry and modernize production capacities. According to Ministry of Finance data, the initial volume of approved subsidies was 136.3 million som.

136.3million som (initial plan)
100million som (reduction amount)

Industry Status and Lending Terms

The preferential lending project aims to develop domestic production, as currently about 96% of the market demand for medicines and medical devices is covered by imports. The share of the pharmaceutical industry in the total industrial production volume of the Kyrgyz Republic is approximately 0.1%.

  • Preferential rates: 3% and 5% per annum
  • Lending terms: up to 10 and 12 years
  • Grace period for principal repayment: up to 24 months

Manufacturers in the republic — Approximately 30 manufacturers of medicines and 16 manufacturers of medical devices are operating in the country.